CNBC’s Angelica Peebles and Novartis CEO Vas Narasimhan join 'Squawk Box' to discuss the company's drug pipeline, managing patent cliffs, drug pricing under Trump, and more. TikTok was gone.

Novartis’ new CEO Vas Narasimhan has shown his priorities by promoting the company’s digital chief to the executive committee. New broom and chief digital officer Bertrand Bodson has been ...

ZURICH (Reuters) - Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview on Saturday, with the pharmaceuticals giant ...

Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs. CEO Vas Narasimhan said the company was researching treatments that deal ...

Novartis CEO Vas Narasimhan talks to CNBC about the company's latest results and the potential impact of the U.S. election on the business. New Canadian PM Mark Carney vows to fight US trade war ...

Novartis CEO Vas Narasimhan weighs in on the impact of the new U.S. administration and artificial intelligence on the pharmaceutical industry, as well as the possibility of further acquisitions.

Vas Narasimhan, the CEO of Novartis, discusses the Swiss pharmaceutical company's first-quarter earnings. MAGA divided as Trump turns on Putin 'Trash' found deep inside a Mexican cave turns out to ...

CEO Vas Narasimhan highlighted Novartis' strong performance in Q4 2024, with sales increasing 16% and core operating income ...

Positioning itself as a pure-play innovative medicines company, Novartis is bullish about the growth towards 2030 by placing an emphasis on a streamlined portfolio to drive sales, says CEO Vas ...

The CEO of Novartis said Wednesday that the Swiss ... on areas where it can build a "unique position." Speaking to CNBC, Vas Narasimhan said that the company was researching treatments that ...